Key result
Splenectomy reduces HbS by ~40 percentage points in pediatric sickle cell anemia.
Case Report (n=3)
Answers are grounded in this paper and cite their sources.
Reports that splenectomy reduces hemoglobin S levels in children with sickle cell anemia and hypersplenism, indicating potential for improved stroke prevention.
Chronic transfusion therapy with the goal of maintaining a hemoglobin (Hb) S <30% is the primary recommended treatment for children with sickle cell anemia and a history of overt stroke or abnormal transcranial Doppler examination. We report chronic hypersplenism as a cause of poor HbS% control in 3 children on chronic transfusion therapy for stroke prevention. Splenectomy resulted in a 39.77% (95% confidence interval, 34.3-45.3, P<0.0001) mean reduction in HbS% with no perioperative or infectious complications suggesting the need for additional research into splenectomy as a therapeutic option for select high-risk children to optimize transfusion therapy for stroke prevention.
No takes yet. Share an insight, caveat, or question.
Black et al. (2018) conducted a case report in Sickle cell anemia with chronic hypersplenism on chronic transfusion therapy for stroke prevention (n=3). Splenectomy vs. Pre-splenectomy status on chronic transfusion therapy was evaluated on Mean reduction in hemoglobin S percentage (HbS%) (MD 39.77%, 95% CI 34.3-45.3, p=<0.0001). Splenectomy resulted in a 39.77% mean reduction in HbS% without perioperative or infectious complications in 3 children with sickle cell anemia.
Synapse has enriched 10 related papers. Consider them for comparative context: